Analysis of the prevalence of arterial hypertension in the child population of the city of Grodno in the pre-covid and during the SARS-CоV-2 pandemic period

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

BACKGROUND: One of the leading problems in pediatric cardiology in recent years has become arterial hypertension, which worldwide tends to increase the share of this pathology in the structure of cardiovascular diseases.

AIM: The aim of the study is to analyze the prevalence of arterial hypertension in the children’s population of Grodno in the pre-COVID period and during the SARS-CoV-2 pandemic.

MATERIALS AND METHODS: The level of the incidence of arterial hypertension, gender and age characteristics of the pathology were studied using reports on medical care for children (Form 1 children of the Ministry of Health) for 2010–2019, analytical and market reports, reviews and certificates of the chief freelance pediatric cardiologist of the Health Department of the Grodno Region, chief physicians and city pediatricians. During the period of work in the time of the SARS-CoV-2 pandemic from January 2021 to September 2021, the course of 99 cases of arterial hypertension in children was analyzed.

RESULTS: An increase in the overall incidence of arterial hypertension in children from 55.67 to 99.92 was established in Grodno, and a relative pattern of reliability of incidence occurred, the incidence was 27.33 (2010) and 28.11 (2019) cases per 100,000 children early age, and a 1.5-fold increase in the share of this pathology in the structure of cardiovascular diseases over the analyzed period. Almost the same proportion of cases of arterial hypertension was revealed in the entire children’s population of Grodno both before the pandemic and during the pandemic.

CONCLUSIONS: For the period 2010–2019, an increase in the overall incidence of arterial hypertension in the children’s population of Grodno was revealed. Compared with the pre-COVID period during the SARS-CoV-2 pandemic, the prevalence of newly diagnosed hypertension in the same population has not changed.

全文:

受限制的访问

作者简介

Natalya Tomchyk

Grodno State Medical University

编辑信件的主要联系方式.
Email: nv.tomchyk@gmail.com

MD, PhD, Assistant Professor, Head of the Department of Polyclinic Pediatrics

白俄罗斯, Grodno

Nella Paramonova

Grodno State Medical University

Email: pulmon@bk.ru

MD, PhD, Dr. Sci. (Med.), Professor, Head of the 2nd Department of Children's Diseases

白俄罗斯, Grodno

Larisa Arzhanovich

Children’s Central Clinical Polyclinic

Email: dgp-1@mail.grodno.by

Pediatric Cardiorematologist, Pediatric Department

白俄罗斯, Grodno

Alicia Kizelevich

Grodno Regional Children’s Clinical Hospital

Email: poliklinika.ped@gmail.com

Head Pediatric Department

白俄罗斯, Grodno

参考

  1. Tomchik NV, Paramonova NS, Matvejchik AI. Diagnosis, treatment and prevention of arterial hypertension in children. What has changed in recent years. Cardiology in Belarus. 2022;14(2):238–248. (In Russ.) doi: 10.34883/pi.202214.2.008
  2. Archbold KH, Vasquez MM, Goodwin JL, et al. Effects of sleep patterns and obesity on increases in blood pressure in a 5-year period: report from the Tucson Children’s Assessment of Sleep Apnea Study. J Pediatr. 2012;161(1):26–30. doi: 10.1016/j.jpeds.2011.12.034
  3. Brandão de Souza C, Mill JG, Salaroli LB, et al. Prevalence of hypertension in children from public schools. J Cardiovasc Sciences. 2017;30(1):42–51. doi: 10.5935/2359-4802.20170023
  4. Cheung EL, Bell CS, Samuel JP, et al. Race and obesity in adolescent hypertension. Pediatrics. 2017;139(5): e20161433. doi: 10.1016/j.jpeds.2011.07010
  5. Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescent. Pediatrics. 2017;140(3): e20171904. doi: 10.1542/9781610024310-part03-ch13
  6. Flynn JT. The hypertensive neonate. Semin Fetal Neonatal Med. 2020;25(5):101–138. doi: 10.1016/j.siny.2020.101138
  7. Laine MK, Kujala UM, Eriksson JG, et al. Former male elite athletes and risk of hypertension in later life. J Hypertens. 2015;33(8):1549–1554. doi: 10.1097/hjh0000000000000601
  8. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv. 2021;11(1):16144. doi: 10.1101/2021.01.27.21250617
  9. Lurbe E, Torro I, Garcia-Vicent C, et al. Blood pressure and obesity exert independent influences on pulse wave velocity in you. Hypertension. 2012;60(2): 550–555. doi: 10.1161/hypertensionaha.112.194746
  10. Negroni-Balasquide XB. Is one measurement enough to evaluate blood pressure among adolescents? A blood pressure screening experience in more than 9000 children with a subset comparison of auscultatory to mercury measurements. J Am Soc Hypertens. 2016;10(2):95–100. doi: 10.1016/j.jash.2015.12.001
  11. Pokharel Y, Macedo FY, Nambi V, et al. Neck circumference is not associated with subclinical atherosclerosis in retired National Football League players. Clin Cardiol. 2014;37(7):402–407. doi: 10.1002/clc.22270
  12. Тheodore RF, Broadbent J, Nagin D, et al. Childhood to early-midlife systolic blood pressure trajectories: early-life predictors, effect modifiers, and adult cardiovascular outcomes. Hypertension. 2015;66(6): 1108–1115. DOI: 10.116/hypertensionaha.115.05831
  13. Tingxuan Y, Yuanjun L, Ying Y, et al. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk. BMC Infect Dis. 2021;21(1):200. doi: 10.1186/s12879-021-05915-0
  14. Tykarski A, Filipiak KJ, Januszewicz A, et al. 2019 Guidelines for the Management of Hypertension. Arterial Hypertension. 2019;23(2):41–87. doi: 10.5603/AH.a2019.0008
  15. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/ APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology: American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6): 1269–1324. doi: 10.1161/hyp.0000000000000065
  16. Willams B, Mancia G. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. doi: 10.1097/hjh.0b013e3282f857e7
  17. Yang J, Zhao F, Zhi L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531–538. doi: 10.1007/s00392-020-01626-9
  18. Zang YX, Zhao JS, Chu ZH. Percentiles of waist-to-sitting-height ratio and its relationship with obesity and elevated blood pressure among children and adolescents in Shandong. Blood Press Monit. 2016;21(1): 33–37. doi: 10.1097/mbp.0000000000000154
  19. Zhendtong Lv, Shubin Lv. Clinical characteristics and analysis of risk factors for disease progression of COVID-19: a retrospective cohort study. Int J Biol Sci. 2021;17(1):1–7. doi: 10.7150/ijbs.50654
  20. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi: 10.1016/0140-6736(20)30566-3

补充文件

附件文件
动作
1. JATS XML
2. Fig. 1. General and primary incidence of arterial hypertension in children in 2010–2019: а — general incidence of arterial hypertension; b — primary incidence of arterial hypertension. The incidence is calculated per 100,000 children

下载 (277KB)
3. Fig. 2. Place of arterial hypertension in the structure of diseases of the circulatory system in children of Grodno

下载 (180KB)
4. Fig. 3. Gender structure of children with arterial hypertension for the period 2010–2019

下载 (177KB)
5. Fig. 4. Age structure of children with newly diagnosed arterial hypertension (2019)

下载 (83KB)

版权所有 © Eco-Vector, 2023



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 69634 от 15.03.2021 г.


##common.cookie##